ARTHEx Biotech Gets FDA Fast Track for ATX-01 in DM1
ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast...